January 25, 2022

News

News Network

North Carolina Sport Supplement Company and Its Owner Plead Guilty to Unlawful Distribution of Steroid-like Drugs

13 min read
<div>A North Carolina resident and his sport supplement company pleaded guilty today to a felony charge relating to the introduction of unapproved new drugs into interstate commerce, the Department of Justice announced.</div>

A North Carolina resident and his sport supplement company pleaded guilty today to a felony charge relating to the introduction of unapproved new drugs into interstate commerce, the Department of Justice announced.

Brian Michael Parks, 47, of Apex, North Carolina, and MedFitRX, Inc, now known as MedFit Sarmacuticals Inc., a sport supplement company based in Cary, North Carolina, pleaded guilty in U.S. District Court for the Western District of Virginia to one count of distributing unapproved new drugs with the intent to mislead and defraud the Food and Drug Administration (FDA) and consumers. Parks admitted that, from approximately June 2017 to September 2019, he and his company unlawfully distributed Selective Androgen Receptor Modulators (SARMs) and other substances that the FDA has not approved, including Ostarine (MK-2866), Ligandrol (LGD-4033), and Testolone (RAD-140). SARMs are synthetic chemicals designed to mimic the effects of testosterone and other anabolic steroids. The FDA has long warned against the use of SARMs like those found in MedFit products, including stating in a 2017 warning letter to another firm that SARMs have been linked to life-threatening reactions including liver toxicity, and have the potential to increase the risk of heart attack and stroke.

“Drugs must undergo FDA approval to ensure they are safe and effective for the public, and this defendant put consumers at risk by deliberately ignoring that process,” said Acting Assistant Attorney General Jeffrey Bossert Clark of the Justice Department’s Civil Division. “The Department of Justice will continue to work hand-in-hand with FDA to investigate and prosecute anyone who puts personal profit before public health.” 

“FDA enforces laws that are designed to protect the public health by ensuring, among other things, that drugs are safe and effective for their intended uses. Drugs disguised as supplements, of unknown origin and possibly toxic ingredients, that are manufactured and distributed outside the FDA’s oversight, endanger consumers,” said Assistant Commissioner for Criminal Investigations Catherine A. Hermsen. “We remain committed to pursuing and bringing to justice those who mislead the public and attempt to subvert the regulatory functions of the FDA by distributing unapproved and potentially dangerous products.” 

“Parks and his company put his customers’ health at risk when he unlawfully distributed drugs without their being FDA approved,” said Acting U.S. Attorney Bubar. “FDA regulations are integral to safeguarding consumers, and I am proud of our federal team that took on this investigation to ensure the process and the public are protected.”

In connection with his plea, Parks agreed to forfeit $1.2 million, reflecting the amount of MedFitRX products he sold across the United States through retail outlets and over the internet.

In pleading guilty, Parks also admitted that he intended to mislead and defraud the FDA and consumers by omitting ingredients on MedFitRX product labels, falsely claiming MedFitRX was licensed and registered to sell these new drugs, importing raw drug ingredients with the intent to avoid regulatory scrutiny, and misrepresenting MedFitRX products as “dietary supplements” or “sports supplements” to create the impression that they were safe and legal to use. 

U.S. District Judge James P. Jones heard the defendants’ guilty pleas in federal court in Abingdon, Virginia, and set sentencing for Feb. 16, 2021.

Assistant U.S. Attorney Randy Ramseyer of the U.S. Attorney’s Office for the Western District of Virginia and Trial Attorney Speare Hodges of the Department of Justice Civil Division’s Consumer Protection Branch are prosecuting the case. This matter was investigated by the FDAs Office of Criminal Investigations.

News Network

  • Two men sent to prison for trafficking troubled teenager
    In Justice News
    Two Houstonians are on [Read More…]
  • Norway Travel Advisory
    In Travel
    Reconsider travel to [Read More…]
  • Businessman Indicted for Not Reporting Foreign Bank Accounts and Filing False Documents with the IRS
    In Crime News
    A federal grand jury in Alexandria, Virginia, returned an indictment on March 3, 2021, charging a Virginia man with failing to file Reports of Foreign Bank and Financial Accounts (FBARs) and filing false documents with the IRS. According to the indictment, Azizur Rahman of Herndon, had a financial interest in and signature authority over more than 20 foreign financial accounts, including accounts held in Switzerland, the United Kingdom, the Republic of Singapore, and Bangladesh. From 2010 through 2016, Rahman allegedly did not disclose his interest in all of his financial accounts on annual FBARs, as required by law. Rahman also allegedly filed false individual tax returns for the tax years 2010 through 2016 that did not report to the IRS all of his foreign bank accounts and income.
    [Read More…]
  • The Importance of Diversity and Inclusion in Diplomacy: A Conversation with Security Engineering Officer Rahim Theriot
    In Crime Control and Security News
    Bureau of Diplomatic [Read More…]
  • Drug trafficker from Canada sent to prison
    In Justice News
    A 51-year-old woman has [Read More…]
  • Defense Logistics: Army and Marine Corps’s Individual Body Armor System Issues
    In U.S GAO News
    Since combat operations began in Iraq and Afghanistan, U.S. forces have been subjected to frequent and deadly attacks from insurgents using various weapons such as improvised explosive devices (IED), mortars, rocket launchers, and increasingly lethal ballistic threats. Since 2003, to provide protection from ballistic threats, U.S. Central Command (CENTCOM), which is responsible for operations in Iraq and Afghanistan and other areas, has required service members and Department of Defense (DOD) civilians in its area of operations to be issued the Interceptor Body Armor (IBA) system. Used by all U.S. military service members and DOD civilians in the area of operations, the IBA consists of an outer tactical vest with ballistic inserts or plates that cover the front, back, and sides. As the ballistic threat has evolved, ballistic requirements have also changed. The vest currently provides protection from 9mm rounds, while the inserts provide protection against 7.62mm armor-piercing rounds. Additional protection can also be provided for the shoulder, throat, and groin areas. Concerns also regarding the level of protection and amount of IBA needed to protect U.S. forces have occurred in recent years, prompted by a number of reports, newspaper articles, and recalls of issued body armor by both the Army and the Marine Corps. In May 2005, the Marine Corps recalled body armor because it concluded that the fielded body armor failed to meet contract specifications, and in November 2005, the Army and Marine Corps recalled 14 lots of body armor that failed original ballistic testing. Additionally, in April 2005, we reported on shortages of critical force protection items, including individual body armor. Specifically, we found reasons for the shortages in body armor were due to material shortages, production limitations, and in-theater distribution problems. In the report, we did not make specific recommendations regarding body armor, but we did make several recommendations to improve the effectiveness of DOD's supply system in supporting deployed forces for contingencies. DOD agreed with the intent of the recommendations and cited actions it had or was taking to eliminate supply chain deficiencies. Congress has expressed strong interest in assuring that body armor protects ground forces. Additionally, as part of our efforts to monitor DOD's and the services' actions to protect deployed ground forces, we reviewed the Army and Marine Corps's actions to address concerns regarding body armor to determine if they had taken actions to address these concerns. Because of broad congressional interest in the adequacy of body armor for the ground forces, we prepared this report under the Comptroller General's authority to conduct evaluations on his own initiative. Our objectives for this review were to determine to what extent the Army and Marine Corps (1) are meeting the theater requirements for body armor, (2) have the controls in place to assure that the manufacturing and fielding of body armor meet requirements, and (3) are sharing information regarding their efforts on body armor ballistic requirements and testing.In this review, we found that the Army and Marine Corps have taken several actions to meet theater requirements, assure testing, and share information on body armor. We also found that contractors and non-DOD civilians receive body armor if this provision is included in a negotiated contract. Specifically, we found that the Army and Marine Corps are currently meeting theater ballistic requirements and the required amount needed for personnel in theater, including the amounts needed for the surge of troops into Iraq; have controls in place during manufacturing and after fielding to assure that body armor meets requirements; and share information regarding ballistic requirements and testing, and the development of future body armor systems, although they are not required to do so. Regarding contractors or non-DOD civilians, we found that DOD Instruction 3020.41 allows DOD to provide body armor to contractors where permitted by applicable DOD instructions and military department regulations and where specified under the terms of the contract. CENTCOM's position is that body armor will be provided to contractors if it is part of a negotiated contract.
    [Read More…]
  • Panama’s Independence Day
    In Crime Control and Security News
    Michael R. Pompeo, [Read More…]
  • Oil Trader Indicted in International Bribery and Money Laundering Conspiracy Involving Corrupt Payments to Ecuadorian Officials
    In Crime News
    A federal grand jury in [Read More…]
  • Leader of a Sophisticated Drug Trafficking Organization and Prolific Ally of the Sinaloa Cartel Sentenced
    In Crime News
    A Mexican national was sentenced today in the U.S. District Court for the District of Columbia to 22 years in prison for her role in an international drug trafficking conspiracy to transport into the United States thousands of kilograms of cocaine and dozens of pounds of methamphetamine.
    [Read More…]
  • South Texan handed significant sentence for trafficking cocaine
    In Justice News
    A 46-year-old Alton man [Read More…]
  • The United States Condemns Venezuela’s Fraudulent Legislative Elections
    In Crime Control and Security News
    Michael R. Pompeo, [Read More…]
  • Former Ericsson Employee Charged for Role in Foreign Bribery Scheme
    In Crime News
    A federal indictment was unsealed today in the Southern District of New York charging a former employee of the Swedish multinational telecommunications company Telefonaktiebolaget LM Ericsson (“Ericsson” or “the Company”) for his alleged role in a scheme to pay approximately $2.1 million in bribes to high-level government officials in the Republic of Djibouti and conspiring to launder funds to promote the scheme. The defendant remains at large.
    [Read More…]
  • Justice Department Requires Substantial Divestitures and Waiver of a Non-Compete for S&P to Proceed with its Merger with IHS Markit
    In Crime News
    The Department of Justice announced today that it will require S&P Global Inc. (S&P) to divest three of IHS Markit Ltd.’s (IHSM) price reporting agency (PRA) businesses to resolve antitrust concerns arising from their proposed $44 billion merger. PRAs provide critical price discovery for numerous commodity markets, including markets where trades are done off-exchange in private transactions that are not subject to reporting obligations.  The divestitures of Oil Price Information Services (OPIS), Coals, Metals, and Mining (CMM), and PetrochemWire (PCW) will maintain competition in PRA services and protect customer access to essential pricing information. In addition, the department will require OPIS to end a 20-year non-compete with GasBuddy, a popular crowd-sourced retail gas price information app that has long provided OPIS with pricing data for resale to commercial customers. This non-compete has effectively prevented GasBuddy — a company well positioned to enter the retail gas price data market — from launching a data service that would compete with OPIS.
    [Read More…]
  • COVID-19: Efforts to Increase Vaccine Availability and Perspectives on Initial Implementation
    In U.S GAO News
    What GAO Found The federal government has taken several actions to increase the availability of COVID-19 vaccine doses and indicated it expects to have enough doses available for all adults in the United States by the end of May. As of April 1, 2021, the government had purchased 1.2 billion doses of one- and two-dose regimen vaccines. Also, vaccine companies reported making additional manufacturing sites operational, among other actions to expand capacity and mitigate challenges. Federal officials said projecting future availability of vaccine doses can be difficult, in part because of uncertainty surrounding complex manufacturing processes. Given this uncertainty, coupled with the significant manufacturing and distribution increases needed to have enough vaccine doses available for all adults, managing public expectations is critical. GAO's prior work has found that timely, clear, and consistent communication about vaccine availability is essential to ensure public confidence and trust, especially as initial vaccine implementation did not match expectations. COVID-19 Vaccination Site Stakeholders GAO interviewed identified challenges with initial COVID-19 vaccine implementation. For example, some stakeholders said states often did not have information critical to distribution at the local level, such as how many doses they would receive and when. The federal government has begun initiatives—outlined in a national response strategy—to improve implementation, such as creating new vaccination sites. In its March 2021 distribution strategy, CDC provided a high-level description of its activities and noted that more details would be included in future reports to Congress. To meet the expectations set by recent announcements, such as the planned expansion of vaccine eligibility to all adults and the introduction of tools to help individuals find vaccines, it will be imperative that the federal government effectively coordinate and communicate its plans, as GAO recommended in September 2020. Why GAO Did This Study Providing the public with safe and effective vaccines to prevent COVID-19 is crucial to mitigating the public health and economic impacts of the disease. The U.S. had almost 30 million reported cases and over 545,000 reported deaths as of March 27, 2021. The federal government took a critical step in December 2020 in authorizing the first two COVID-19 vaccines and beginning distribution of doses across the nation. The government had distributed about 180.6 million vaccine doses, and about 147.8 million doses had been administered, as of March 27, 2021, according to Centers for Disease Control and Prevention (CDC) data. The CARES Act includes a provision for GAO to report on its ongoing monitoring and oversight efforts related to the COVID-19 pandemic. This report examines, among other issues, actions the federal government has taken to increase the availability of COVID-19 vaccine doses, and challenges with initial vaccine implementation—that is, prioritizing, allocating, distributing, and administering vaccine doses—identified by stakeholders and steps the federal government has taken to improve vaccine implementation. GAO reviewed documents from the Departments of Defense and Health and Human Services, transcripts of public briefings, data from CDC, and interviewed or received written responses from federal officials, vaccine company representatives, and select public health stakeholders. GAO incorporated technical comments from the Department of Defense, the Department of Health and Human Services, and the Federal Emergency Management Agency as appropriate. For more information, contact Alyssa M. Hundrup at (202) 512-7114 or hundrupa@gao.gov.
    [Read More…]
  • Secretary Antony J. Blinken And Brazilian Foreign Minister Carlos Franca Before Their Meeting
    In Crime Control and Security News
    Antony J. Blinken, [Read More…]
  • Sixth Former Tennessee Corrections Officer Pleads Guilty to Federal Offenses Arising out of a Cover Up of Staff Assault of an Inmate
    In Crime News
    Former Tennessee Department of Corrections (TDOC) Corporal Tommy Morris, 29, pleaded guilty to conspiring to cover up the beating of an inmate and to encouraging other officers to provide false information to investigators, the Justice Department announced today.
    [Read More…]
  • Department of Justice Announces Arrests in Conspiracy and Dog Fighting Ring Investigation
    In Crime News
    An indictment was unsealed today charging 11 individuals on a 136-count federal indictment including violations of drug conspiracy, drug possession, and drug possession with the intent to distribute, and violations of the dog fighting prohibitions of the federal Animal Welfare Act, and conspiracy to commit the same.
    [Read More…]
  • U.S. Asia-Pacific Economic Cooperation (APEC) Travel Card Program FAQs
    In Travel
    Content currently [Read More…]
  • Secretary Blinken to Deliver Remarks to the Press
    In Crime Control and Security News
    Office of the [Read More…]
  • Secretary of State Antony J. Blinken’s Meeting with Emirati Foreign Minister Sheikh Abdullah bin Zayed, Indian External Affairs Minister Dr. Subrahmanyam Jaishankar, and Israeli Foreign Minister and Alternate Prime Minister Yair Lapid
    In Crime Control and Security News
    Office of the [Read More…]

Crime

Network News © 2005 Area.Control.Network™ All rights reserved.